Novartis AG ADR diskutieren
Novartis AG ADR
WKN: 907122 / Symbol: NVS / Name: Novartis / Aktie / Pharmazeutika / Large Cap /
124,50 €
1,21 %
Novartis AG (NYSE: NVS) is now covered by analysts at StockNews.com. They set a "strong-buy" rating on the stock.
Ratings data for NVS provided by MarketBeat
Novartis AG (NYSE: NVS) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $120.00 price target on the stock.
Ratings data for NVS provided by MarketBeat
Novartis AG (NYSE: NVS) had its price target raised by analysts at Jefferies Financial Group Inc. from $121.00 to $122.50. They now have a "buy" rating on the stock.
Ratings data for NVS provided by MarketBeat
Novartis AG (NYSE: NVS) was downgraded by analysts at HSBC Holdings plc from a "hold" rating to a "reduce" rating.
Ratings data for NVS provided by MarketBeat
Novartis AG (NYSE: NVS) was upgraded by analysts at Deutsche Bank Aktiengesellschaft from a "hold" rating to a "buy" rating.
Ratings data for NVS provided by MarketBeat
Novartis AG (NYSE: NVS) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Ratings data for NVS provided by MarketBeat
Novartis AG (NYSE: NVS) had its "underweight" rating re-affirmed by analysts at Barclays PLC.
Ratings data for NVS provided by MarketBeat
Novartis AG (NYSE: NVS) was upgraded by analysts at BNP Paribas to a "strong-buy" rating.
Ratings data for NVS provided by MarketBeat
Novartis (NYSE:NVS) had its "buy" rating reaffirmed by analysts at Deutsche Bank Aktiengesellschaft.
Ratings data for NVS provided by MarketBeat
Novartis (NYSE:NVS) had its "sell" rating reaffirmed by analysts at The Goldman Sachs Group, Inc.. They now have a $118.00 price target on the stock, down previously from $119.00.
Ratings data for NVS provided by MarketBeat
Novartis (NYSE:NVS) was upgraded by analysts at Bank of America Corporation from a "neutral" rating to a "buy" rating.
Ratings data for NVS provided by MarketBeat
Novartis (NYSE:NVS) was upgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating.
Ratings data for NVS provided by MarketBeat
Novartis (NYSE:NVS) had its "buy" rating reaffirmed by analysts at Deutsche Bank Aktiengesellschaft.
Ratings data for NVS provided by MarketBeat
Neueste Beiträge
Evercore_ISI in Discuss Western Digital Corp.